Prolactinomas are the most common secretory tumor of the pituitary gland. Clinical symptoms may be due to prolactin oversecretion, localized mass effect, or a combination of both. Although the mainstay of prolactinoma management is medical therapy with dopamine agonists, endoscopic endonasal or transcranial surgery, radiation therapy, or a combination of these is an important treatment option in select cases. This article discusses prolactinoma phenotypes, clinical presentations, and clinically pertinent medical and surgical considerations when managing these tumors.
Keywords: Dopaminergic therapy; Pituitary tumor; Prolactin; Prolactinoma; Surgical considerations; Transsphenoidal surgery.
Copyright © 2021 Elsevier Inc. All rights reserved.